EMA reviews valproate in pregnancy
The European Medicines Agency (EMA) is reviewing the use of valproate in pregnant women. Evidence from earlier this year suggests that its effects on an unborn child may be more serious than previously thought
The European Medicines Agency (EMA) is reviewing the use of valproate in pregnant women. Evidence from earlier this year suggests that its effects on an unborn child may be more serious than previously thought
